PADGETT PARKER

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical ABILENE, TX NPI 1083158802

General Payments — all program years on this page

$522.35

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $468.35 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $468.3522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $35.102
2023 $18.901
2024 $468.3522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078680002 Janssen Biotech, Inc. $13.25 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078680029 Janssen Biotech, Inc. $20.63 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078914899 Actelion Pharmaceuticals US, Inc. $25.57 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087328291 Novartis Pharmaceuticals Corporation $26.44 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087328297 Novartis Pharmaceuticals Corporation $22.59 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089371110 Sandoz Inc. $14.15 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101732176 E.R. Squibb & Sons, L.L.C. $18.73 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101732230 E.R. Squibb & Sons, L.L.C. $14.52 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107791223 ABBVIE INC. $14.06 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107791228 ABBVIE INC. $23.93 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107791232 ABBVIE INC. $22.40 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107791237 ABBVIE INC. $23.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116032235 GlaxoSmithKline, LLC. $17.51 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116488097 GlaxoSmithKline, LLC. $19.84 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117347092 Amgen Inc. $13.80 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117347094 Amgen Inc. $29.86 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117347096 Amgen Inc. $23.58 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117347098 Amgen Inc. $26.79 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117347100 Amgen Inc. $33.79 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127054657 Kyowa Kirin, Inc. $16.71 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143458704 UCB, Inc. $28.07 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143458709 UCB, Inc. $19.09 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.